166 employees
AVEO is a biopharmaceutical company that offers drug development strategies for targeted cancer therapeutics.
2001
$35M
from 3 investors over 3 rounds
AVEO Oncology raised $35M on August 10, 2020
Investors: Hercules Capital, Inc.
AVEO Oncology raised $17M on May 13, 2016
Investors: Perceptive Advisors and New Leaf Venture Partners